2024-03-06 REL RCSB RCSB RCSB 2020-08-20 2021-03-31 2021-03-31 2024-03-06 Structure of human TRPA1 in complex with antagonist compound 21 Rohou A Rouge L Chen H TRPA1, channel, agonist, MEMBRANE PROTEIN, MEMBRANE PROTEIN-Antagonist complex Terrett JA Chen H Shore DG Villemure E Larouche-Gauthier R Dery M Beaumier F Constantineau-Forget L Grand-Maitre C Lepissier L Ciblat S Sturino C Chen Y Hu B Lu A Wang Y Cridland AP Ward SI Hackos DH Reese RM Shields SD Chen J Balestrini A Riol-Blanco L Lee WP Liu J Suto E Wu X Zhang J Ly JQ La H Johnson K Baumgardner M Chou KJ Rohou A Rouge L Safina BS Magnuson S Volgraf M Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action via Cryogenic Electron Microscopy. J.Med.Chem. US 64 3843 3869 2021 33749283 doi:10.1021/acs.jmedchem.0c02023 0022-2623 0151 JMCMAR 7jup FULLOVERLAP TRPA1 bound by antagonist compound 21 TRPA1 bound by antagonist compound 21 0 1 Homo sapiens Transient receptor potential cation channel subfamily A member 1 Homo sapiens 0.072622125 4 Spodoptera frugiperda LEVO SPLHFAASYGRINTCQRLLQDISDTRLLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGALFLSDHNGWTALHHASMGGYT QTMKVILDTNLKCTDRLDEDGNTALHFAAREGHAKAVALLLSHNADIVLNKQQASFLHLALHNKRKEVVLTIIRSKRWDE CLKIFSHNSPGNKCPITEMIEYLPECMKVLLDFCMLHSTEDKSCRDYYIEYNFKYLQCPLEFTKKTPTQDVIYEPLTALN AMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGSYCLGLIPMTILVVNIKPGMAFNSTGIINETSDHSEILDTTNS YLIKTCMILVFLSSIFGYCKEAGQIFQQKRNYFMDISNVLEWIIYTTGIIFVLPLFVEIPAHLQWQCGAIAVYFYWMNFL LYLQRFENCGIFIVMLEVILKTLLRSTVVFIFLLLAFGLSFYILLNLQDPFSSPLLSIIQTFSMMLGDINYRESFLEPYL RNELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIADVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVYP NKPRSGGMLFHIFCFLFCTGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQHELIKLIIQKMEIISET O75762 1-({3-[(3R,5R)-5-(4-fluorophenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl}methyl)-7-methyl-1,7-dihydro-6H-purin-6-one 0.00039637499999999997 4 VKM singleParticle particle 0.33 8.199999999999999 25.0 Tris 150.0 NaCl NaCl 0.5 TCEP UltrAuFoil R2/2 GOLD 300 GOLD HOLEY 25.0 PLASMA CLEANING OTHER 0.1
Solarus plasma cleaner
 ETHANE 100 277 FEI VITROBOT MARK IV
Triple blot. Put blot in vitroblot Apply 3.5ul to grid, wait 30sec, blot manually Apply 3.5ul to grid, wait 30sec, blot manually, apply final 3.5ul, final blot by vitrobot (3.5s).
FEI TITAN KRIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 300 70.0 2.7 165000.0 FEI TITAN KRIOS AUTOGRID HOLDER NITROGEN GIF Bioquantum 20 GATAN K2 QUANTUM (4k x 4k) COUNTING 1-40 1 8915 1.6 41.8 1 395169 1 C4 FOURIER SPACE 3.05 FSC 0.143 CUT-OFF cisTEM PHENIX density modification
No data beyond 4.4 A were used during refinement.
101265 RANDOM ASSIGNMENT cisTEM OTHER cisTEM 1 cisTEM 3D reconstruction emd_22490.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 114 99 99 0 15 15 99 99 114 124.937996 124.937996 143.868 90.0 90.0 90.0 Z Y X -1.6093935 2.9291418 -0.000000000001662 0.2242722 1.262 1.262 1.262 0.46 AUTHOR Output from density modification in Phenix 6X2J PDB experimental model FLEXIBLE FIT REAL emd_22490_half_map_2.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 128 128 128 0 0 0 128 128 128 161.536 161.536 161.536 90.0 90.0 90.0 X Y Z -6.6475487 11.944350999999999 0.09580158 1.168907 1.262 1.262 1.262 AUTHOR half map 2 emd_22490_half_map_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 128 128 128 0 0 0 128 128 128 161.536 161.536 161.536 90.0 90.0 90.0 X Y Z -6.461459 11.741483000000001 0.09521408 1.1697317 1.262 1.262 1.262 AUTHOR Half-map 1